POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Medstar Health Research Institute
- Study ID
- NCT06634459
- Status
- Recruiting
Conditions
- Pelvic Organ Prolapse
- Prolapse
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Reia System — DEVICEReia pessary
- Standard of Care Pessary — DEVICEGellhorn pessary or ring with/without support without knob pessary
Study Details
This multi-centered, randomized controlled trial will evaluate the safety and efficacy of home use of the novel Reia System (RS), which includes the Reia pessary and applicator, compared to standard pessary care (Gellhorn or ring with/without support without knob) among women with stage II-IV pelvic organ prolapse (POP). A total of 200 participants will be recruited among pessary naïve patients who are symptomatic and choose a vaginal pessary for management of their POP from study sites specializing in Urogynecology and Reconstructive Pelvic Surgery (URPS). Participants will be assigned via 1:1 randomization using computer generated numbers in permutated groups of variable block sizes to either the intervention (the Reia System, RS) or standard pessary care (SPC) stratified by site. Participation in this trial will involve a total of four visits over six months. The primary outcome measure will be satisfaction measured at the six-month time point. Secondary outcomes will include validated surveys to assess quality of life, number of self-management events, ease/difficulty of pessary insertion/removal, importance of ability to self-manage pessary, and adverse events. Specific Aims Aim 1: To compare satisfaction with pessary use and management between subjects randomized to the Reia System and those randomized to standard of care pessary. Aim 2: To assess successful fitting, number of refitting visits, number of self-management events and continued pessary use over a 6-month period between subjects randomized to the Reia System and those randomized to standard of care pessary. Aim 3: To compare ease/difficulty of pessary use and importance of ability to self-manage, as well as quality of life over a 6-month period between subjects randomized to the Reia System and those randomized to standard of care pessary. Aim 4: To measure rates of adverse events and risk factors for adverse events over a 6-month period between subjects randomized to the Reia System and those randomized to standard of care pessary.
Key Dates
- Start date
- Nov 1, 2024
- Status verified
- Jun 2025
- Primary completion
- Apr 30, 2026
- Completion
- Oct 30, 2026
Study Design
- Enrollment
- 218 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Reia SystemParticipants receiving the commercially available RS will be fit with one of three available pessary sizes and will receive an applicator corresponding to their pessary size.
- Active Comparator: Standard Pessary CareParticipants receiving SPC will be fit with a Gellhorn pessary or ring with/without support without knob pessary per standard clinical protocol.
Primary Outcome Measure
Satisfaction with treatment [ Time Frame: 6 months ]
Central Contacts
- Melissa G Goodwin202-877-3657
- Alexis A Dieter
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35249 | Gabriela Halder, MD (PRINCIPAL_INVESTIGATOR) Holly Richter, MD (SUB_INVESTIGATOR) David Ellington, MD (SUB_INVESTIGATOR) Gena Dunivan, MD (SUB_INVESTIGATOR) Thomas Powell, MD (SUB_INVESTIGATOR) |
| Stanford University | Palo Alto | California | 94304 | Eric Sokol, MD (PRINCIPAL_INVESTIGATOR) |
| MedStar Health | Washington D.C. | District of Columbia | 20010 | Alexis Dieter, MD (PRINCIPAL_INVESTIGATOR) Robert Gutman, MD (SUB_INVESTIGATOR) Cheryl Iglesia, MD (SUB_INVESTIGATOR) Lee Ann Richter, MD (SUB_INVESTIGATOR) Andrew Sokol, MD (SUB_INVESTIGATOR) |
| The University of Chicago | Northbrook | Illinois | 60062 | Margaret Mueller, MD (PRINCIPAL_INVESTIGATOR) Kimberly Kenton, MD (SUB_INVESTIGATOR) Christina Lewicky-Gaupp, MD (SUB_INVESTIGATOR) Sarah Collins, MD (SUB_INVESTIGATOR) Juraj Letko, MD (SUB_INVESTIGATOR) Sandra Valaitis, MD (SUB_INVESTIGATOR) Douglas Russo, MD (SUB_INVESTIGATOR) Iris Burgard, MD (SUB_INVESTIGATOR) |
| Dartmouth-Hitchcock | Lebanon | New Hampshire | 03756 | Kris Strohbehn (PRINCIPAL_INVESTIGATOR) |
| University of New Mexico Health Sciences Center | Albuquerque | New Mexico | 87131 | |
| Atrium Health Wake Forest Baptist | Winston-Salem | North Carolina | 27103 | Katherine Woodburn (PRINCIPAL_INVESTIGATOR) |
| Women & Infants Hospital in Rhode Island | Providence | Rhode Island | 02903 | |
| University of Wisconsin | Madison | Wisconsin | 53711 | Jon Pennycuff (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Birmingham, AL
Related Studies
- Ethicon Pelvic Mesh Post Market Clinical Follow-up RegistryRecruiting · Ethicon, Inc. · New Haven, Connecticut
- A Telehealth Intervention to Increase Patient Preparedness for Surgery in LatinasRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Sequence of Midurethral Sling Placement During Robotic SacrocolpopexyRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Enabling Self-Care for Pessary Users in Rural SettingEnrolling By Invitation · Dartmouth-Hitchcock Medical Center · Lebanon, New Hampshire